VEGFA and cancer: Consistent with these observations, administration of sFlt1 to pregnant rats produces a syndrome that mimics preeclampsia with hypertension, proteinuria, and edema [14], while anti-VEGF therapy in cancer patients has been shown to cause hypertension and proteinuria in cancer patients [15].